Novel polymorphs of the anti-Trypanosoma cruzi drug benznidazole

被引：16

作者：

Honorato, Sara Braga ^{[1
]}

Mendonca, Jorge Souza ^{[2
]}

Boechat, Nubia ^{[2
]}

Oliveira, Alcemira Conceicao ^{[1
]}

Mendes Filho, Josue ^{[1
]}

Ellena, Javier ^{[3
]}

Ayala, Alejandro Pedro ^{[1
]}

机构：

[1] Univ Fed Ceara, Dept Phys, BR-60455760 Fortaleza, Ceara, Brazil

[2] Fundacao Oswaldo Cruz FioCruz, Inst Tecnol Farmacos FarManguinhos, BR-21041250 Rio De Janeiro, Brazil

[3] Univ Sao Paulo, Inst Fis Sao Carlos, BR-13560970 Sao Paulo, Brazil

来源：

SPECTROCHIMICA ACTA PART A-MOLECULAR AND BIOMOLECULAR SPECTROSCOPY | 2014年 / 118卷

基金：

巴西圣保罗研究基金会;

关键词：

Benznidazole; Polymorphism; Hot stage microscopy; Thermal analysis; X-ray powder diffraction; Infrared spectroscopy; PHYSICOCHEMICAL CHARACTERIZATION; MOLECULAR-CRYSTALS; PHARMACEUTICALS;

D O I：

10.1016/j.saa.2013.08.096

中图分类号：

O433 [光谱学];

学科分类号：

0703 ; 070302 ;

摘要：

Benznidazole (N-benzyl-2-(2-nitro-1H-imidazol-1-yl)acetamide), is a nitro-heterocyclic drug used in the treatment of Chagas disease. Despite the fact that this drug was released more than 30 years ago, little information about its solid state properties is available in the literature. In this study, it was verified that this drug exhibits three polymorphs, which were characterized in situ by X-ray powder diffraction, thermal analysis, hot stage microscopy and infrared spectroscopy. The thermodynamic relationships among these polymorphs were also discussed. (C) 2013 Elsevier B.V. All rights reserved.

引用

页码：389 / 394

页数：6

共 50 条

[21] Synthesis and anti-Trypanosoma cruzi activity of β-lapachone analogues
Ferreira, Sabrina Baptista
Salomao, Kelly
da Silva, Fernando de Carvalho
Pinto, Antonio Ventura
Kaiser, Carlos Roland
Pinto, Angelo C.
Ferreira, Vitor Francisco
de Castro, Solange L.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2011, 46 (07) : 3071 - 3077
[22] Specificity and role of anti-Trypanosoma cruzi clearance antibodies
Umekita, LF
Barbaro, KC
Mota, I
BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 1996, 29 (01) : 25 - 31
[23] Approaches for the Development of New Anti-Trypanosoma cruzi Agents
Magalhaes Moreira, Diogo Rodrigo
Lima Leite, Ana Cristina
dos Santos, Ricardo Ribeiro
Soares, Milena B. P.
CURRENT DRUG TARGETS, 2009, 10 (03) : 212 - 231
[24] Microalgae extracts: Potential anti-Trypanosoma cruzi agents?
Veas, Rhonda
Rojas-Pirela, Maura
Castillo, Christian
Olea-Azar, Claudio
Moncada, Mauricio
Ulloa, Pablo
Rojas, Veronica
Kemmerling, Ulrike
BIOMEDICINE & PHARMACOTHERAPY, 2020, 127
[25] Naftifine-analogues as anti-Trypanosoma cruzi agents
Gerpe, Alejandra
Boiani, Lucia
Hernandez, Paola
Sortino, Maximiliano
Zacchino, Susana
Gonzalez, Mercedes
Cerecetto, Hugo
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2010, 45 (06) : 2154 - 2164
[26] Anti-Trypanosoma cruzi Activity of Metabolism Modifier Compounds
Martinez-Peinado, Nieves
Martori, Clara
Cortes-Serra, Nuria
Sherman, Julian
Rodriguez, Ana
Gascon, Joaquim
Alberola, Jordi
Pinazo, Maria-Jesus
Rodriguez-Cortes, Alheli
Alonso-Padilla, Julio
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (02) : 1 - 16
[27] In vitro and in vivo anti-Trypanosoma cruzi activity of a novel nitro-derivative
Muelas-Serrano, S
Le-Senne, A
Fernández-Portillo, C
Nogal, JJ
Ochoa, C
Gómez-Barrio, A
MEMORIAS DO INSTITUTO OSWALDO CRUZ, 2002, 97 (04): : 553 - 557
[28] Screening for anti-Trypanosoma cruzi in blood donors in Argentina
Blejer, JL
Saguier, MC
Salamone, HJ
TRANSFUSION, 2004, 44 (09) : 97A - 97A
[29] Anti-Trypanosoma cruzi(T-cruzi)screening in blood donors.
Remesar, MC
Blejer, JL
Saguier, MC
Ferraro, LE
Salamone, HJ
del Pozo, AE
TRANSFUSION, 1999, 39 (10) : 76S - 76S
[30] Synthesis, cytotoxicity, and anti-Trypanosoma cruzi activity of new chalcones
Aponte, Jose C.
Verastegui, Manuela
Malaga, Edith
Zimic, Mirko
Quiliano, Miguel
Vaisberg, Abraham J.
Gilman, Robert H.
Hammond, Gerald B.
JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (19) : 6230 - 6234

← 1 2 3 4 5 →